Humira
FDA Approves Biosimilar to RA Drug
The FDA approved Simlandi injection, the first interchangeable high-concentration, citrate-free biosimilar to ...
MARCH 11, 2024

First Biosimilar to Humira Launches
Adalimumab-atto, an anti-tumor necrosis factor (TNF)-alpha monoclonal antibody, was the first biosimilar to Humira ...
FEBRUARY 13, 2023

Studies: Most SLE, Arthritis Patients Not at Higher Risk for COVID Hospitalization
Patients with systemic lupus erythematosus or inflammatory arthritis conditions such as rheumatoid arthritis may ...
SEPTEMBER 25, 2020

FDA Approves Amjevita, a Biosimilar to Humira
The anti-inflammatory drug is the fourth biosimilar to be approved in the United States.
SEPTEMBER 29, 2016
